BHVN's Business Model
Biohaven Ltd. is a clinical-stage biopharmaceutical company. The Company focuses on development of therapies for neurological and immunoscience diseases that can change current treatment paradigms.
| Sector & Industry | Healthcare / Biotechnology |
| Website | https://www.biohaven.com |
| CEO (Chief Executive Officer) | Vladimir Coric |
| Number of Employees | |
| IPO date | September 23, 2022 |
BHVN Latest News
|
|
|
|
|
|
|
|
|
|
| Contact | |
|---|---|
| Country | US |
| Address | 215 Church Street |
| City | New Haven |
| State | CT |
| Phone | 203 404 0410 |
| Zip Code | 06510 |
| Other Identifiers | |
| CIK | 0001935979 |
| ISIN | VGG1110E1079 |
| CUSIP | G11196105 |
| Open | 13.9 |
| Previous Close | 13.79 |
| Volume | 1.05 Mil. |
| Average Volume | 2.17 Mil. |
| Day’s Range | 13.85 – 14.18 |
| 52 Week Range | 13.745-55.7 |
| MA (50) | 16.8028 |
| MA (200) | 33.4526 |
| Market Cap | 1.42 Bil. |
| Shares Out. | 102.1 Mil. |
| Earnings Date | Aug 05, 2025 |
| Beta | |
| Last Dividend | |
| EPS | |
| PE | |
